BALYASNY ASSET MANAGEMENT L.P. - 31 Mar 2026 SCHEDULE 13G/A Report for Lexeo Therapeutics, Inc. Common Stock, par value $0.0001 per share (LXEO)

Filing manager: BALYASNY ASSET MANAGEMENT L.P.
Reporting owner: Balyasny Asset Management L.P.
Security: Lexeo Therapeutics, Inc. Common Stock, par value $0.0001 per share
Symbol: LXEO
Shares outstanding: 74,057,214 shares
Disclosed shares: 7,176,144 shares
Ownership percentage: 9.7%
Form type: SCHEDULE 13G/A
Filing time: 15 May 2026, 06:23:32 UTC
Event date: 31 Mar 2026
Previous filing: 17 Feb 2026
SEC filing: View on sec.gov

Key filing fact

BALYASNY ASSET MANAGEMENT L.P. disclosed 9.7% ownership in Lexeo Therapeutics, Inc. Common Stock, par value $0.0001 per share (LXEO) on 31 Mar 2026.

Key facts

BALYASNY ASSET MANAGEMENT L.P. filed SCHEDULE 13G/A for Lexeo Therapeutics, Inc. Common Stock, par value $0.0001 per share (LXEO).
Disclosed ownership: 9.7%.
Date of event: 31 Mar 2026.

This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
You can verify ownership claims directly against the original SEC filing.

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

Reporting persons

Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.

Name	Ownership	Shares Owned	sole voting power	Signature	Title
Balyasny Asset Management L.P.	9.7%	7,176,144	7,176,144	/s/ Scott Schroeder	Scott Schroeder / Authorized Signatory
BAM GP LLC	9.7%	7,176,144	7,176,144	/s/ Scott Schroeder	Scott Schroeder / Authorized Signatory
Balyasny Asset Management Holdings LP	9.7%	7,176,144	7,176,144	/s/ Scott Schroeder	Scott Schroeder / Authorized Signatory
Dames GP LLC	9.7%	7,176,144	7,176,144	/s/ Scott Schroeder	Scott Schroeder / Authorized Signatory
Dmitry Balyasny	9.7%	7,176,144	7,176,144	/s/ Dmitry Balyasny	Dmitry Balyasny / Self

CIK / CUSIP context first

Broader feeds